What is an HIV-1 Genotypic Resistance test and why would someone need it?

Understanding HIV testing can feel overwhelming, particularly when terms like "genotypic resistance testing" appear in conversations with healthcare professionals. Whether you have recently received an HIV-1 diagnosis, are reviewing your current treatment, or simply want to understand what this type of test involves, this article aims to explain the process in a clear, reassuring, and clinically accurate way.

Our clinic provides confidential STI testing services. We do not provide GP services or dermatology consultations, but we can advise on appropriate next steps if further medical care is needed.

What is an HIV-1 Genotypic Resistance Test?

An HIV-1 Genotypic Resistance test is a specialist laboratory analysis that examines the genetic makeup of HIV-1 virus particles present in a blood sample. It is designed to identify specific mutations within the virus that may cause it to respond less effectively — or not at all — to certain antiretroviral medications.

In straightforward terms: this test helps clinicians understand which HIV treatments are likely to work and which may not, based on the unique genetic profile of the virus present in a specific individual.

Key points at a glance:

• The test analyses the genetic sequence of HIV-1 in the blood
• It identifies mutations associated with drug resistance
• Results help guide appropriate antiretroviral therapy (ART) choices
• It is typically performed at the point of HIV diagnosis or when treatment is being reviewed
• Results alone do not provide a full clinical picture — they must be interpreted alongside other clinical factors

Symptoms or test results alone cannot determine treatment suitability. Genotypic resistance testing must be interpreted in the context of a full clinical assessment.

When Could HIV Drug Resistance Become a Concern?

HIV-1 is a virus that replicates rapidly. During replication, genetic mutations can occur — some of which may reduce the effectiveness of antiretroviral drugs. In a 60–80 word summary: drug resistance in HIV-1 may develop when the virus mutates in ways that interfere with how antiretroviral medications work. This can occur over time during treatment, or it may be present at the point of initial infection if the virus was transmitted from someone whose HIV had already developed resistance. Testing helps identify this early.

This does not mean treatment will be ineffective. Many highly effective antiretroviral options exist, and genotypic resistance testing is a tool to ensure the most appropriate therapy is selected.

Understanding HIV-1 and How the Virus Mutates

HIV-1 is the most common strain of HIV globally. Like all viruses, it undergoes replication within the body, and during this process, small genetic errors — known as mutations — can occur naturally.

Some of these mutations are clinically insignificant. Others, however, may affect the regions of the virus targeted by specific antiretroviral drugs. When a mutation alters the viral protein that a drug is designed to block or inhibit, the drug may become less effective.

This does not happen in every case, and it does not happen immediately. However, it is sufficiently common that resistance testing has become a standard part of HIV clinical management in the UK.

Common Reasons Someone May Need an HIV-1 Genotypic Resistance Test

Genotypic resistance testing is not something sought independently in the same way as a standard STI screen. It is typically arranged within the context of HIV care. However, understanding when it may be relevant can be helpful.

Situations where this test may be recommended include:

• Newly diagnosed HIV-1: Testing at diagnosis allows clinicians to identify whether any pre-existing drug resistance is present before treatment begins
• Virological failure: If an individual is already on antiretroviral therapy but their viral load is not suppressing as expected, resistance testing may help identify why
• Change in treatment regimen: If a treatment switch is being considered, resistance testing can inform which alternatives are appropriate
• Transmitted drug resistance: In some cases, HIV transmitted from another person may already carry resistance mutations, even before any treatment has been taken
• Pregnancy: Resistance testing during pregnancy is often recommended to ensure the safest and most effective treatment for both the individual and the child

How Does an HIV-1 Genotypic Resistance Test Work?

The test is performed using a blood sample. In the laboratory, the genetic material (RNA) of the HIV-1 virus is extracted and sequenced. The resulting genetic sequence is then analysed and compared against known databases of HIV mutations and their associated drug resistance profiles.

The process involves:

1. Blood draw — a standard venous blood sample
2. RNA extraction — viral genetic material is isolated
3. Sequencing — the genetic code of the virus is mapped
4. Mutation analysis — results are compared against established resistance databases
5. Clinical interpretation — a specialist interprets the findings in the context of the individual's treatment history and clinical status

Results are typically available within one to two weeks, though timelines may vary depending on the laboratory used.

How Does This Differ From a Standard HIV Test?

A standard HIV test detects whether HIV antibodies or antigens are present in the blood — in other words, it answers the question: has this person been exposed to HIV?

A genotypic resistance test goes several steps further. It is only relevant once HIV infection has already been confirmed. Rather than detecting the presence of HIV, it analyses the characteristics of the virus already present — specifically, its genetic mutations and how those mutations may affect treatment response.

Both types of testing serve important but distinct purposes.

STIs That May Present Alongside HIV

Individuals living with HIV, or those concerned about potential HIV exposure, may also wish to consider testing for other sexually transmitted infections. HIV can increase susceptibility to certain other infections, and some STIs may in turn affect HIV management.

Infections that are commonly screened for alongside HIV include:

• Chlamydia — often asymptomatic; a chlamydia test may provide clarity
• Gonorrhoea — symptoms can vary significantly; gonorrhoea testing is straightforward
• Syphilis — presentations can overlap with other conditions; a syphilis test is advisable following any potential exposure
• Herpes — a herpes test may be appropriate where relevant symptoms or exposure history exist

A full STI screen may be a sensible step for individuals who have had unprotected sex or a new sexual partner, regardless of HIV status.

When Symptoms Are Less Likely to Be Related to Drug Resistance

It is worth noting that HIV drug resistance does not typically cause distinct, recognisable symptoms in isolation. Symptoms often attributed to HIV treatment issues — such as fatigue, nausea, or general unwellness — can have numerous possible causes unrelated to resistance.

These may include:

• Side effects from current medications
• Opportunistic infections
• General illness unrelated to HIV
• Nutritional deficiencies
• Stress or fatigue

Symptoms alone cannot indicate whether drug resistance is present. Only laboratory testing, interpreted within a clinical context, can provide that information.

Frequently Asked Questions

Can I request an HIV-1 Genotypic Resistance test without a prior HIV diagnosis?

This test is only clinically relevant following a confirmed HIV-1 diagnosis. If you are concerned about HIV exposure, a standard HIV test would be the appropriate first step.

Does a resistance mutation mean my treatment will stop working?

Not necessarily. Resistance to one drug does not mean all treatment options are exhausted. There are many antiretroviral classes and combinations available. Your clinical team can use resistance data to select the most appropriate alternative.

How often is resistance testing repeated?

Frequency depends on individual clinical circumstances. It may be repeated if treatment is failing, if a new regimen is being considered, or if there are other clinical reasons to reassess.

Can HIV drug resistance be passed on to someone else?

Yes, in some cases. If a person living with HIV has a resistant strain, that strain — including its resistance mutations — may be transmitted to a partner. This is known as transmitted drug resistance.

Is genotypic resistance testing available privately?

Genotypic resistance testing is a specialist service typically arranged through NHS HIV clinics or specialist private HIV care services. A standard private STI clinic may not offer this directly but can support with related HIV testing and onward referral guidance.

Should I still test for other STIs if I am living with HIV?

Yes. Regular STI screening is advisable for sexually active individuals, including those living with HIV. Many infections can be asymptomatic, and early detection supports better health outcomes.

When to Seek Medical Advice

If you are living with HIV and have concerns about your treatment or viral load, it is important to speak with your HIV specialist or sexual health clinician. You should seek prompt medical advice if you experience:

• Persistent or unexplained symptoms despite treatment
• Signs of a new or worsening infection
• Significant side effects from current medications
• Concerns about your viral load or CD4 count

If symptoms persist or worsen, consultation with an appropriate healthcare service may be advised.

Confidential STI Testing in the UK

If you are concerned about possible HIV exposure or wish to be tested for a range of sexually transmitted infections, confidential STI testing appointments are available at our UK clinic. Testing decisions depend on symptoms, exposure history, and individual risk factors. We are happy to help clarify which tests may be relevant to your circumstances and advise on appropriate next steps.

Visit our main STI testing page or speak with our team for further information.

This article is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Sexual health concerns should be assessed based on individual circumstances. If you are experiencing persistent, severe, or worsening symptoms, consultation with an appropriate healthcare service is advised. Our clinic provides private STI testing services only.